types of glp 1 receptor agonists Classification currently available glucagon-like peptide-1 Association of glucagon-like peptide-1 receptor
Description
Patients should not independently stop therapy without discussing the plan with their care team, because abrupt interruption may affect glucose control or other treatment goals
K., Higa S., Chen S
All 122,124,125,126,127,128 but one 123 study showed a benefit on metabolic parameters
Although is there much benefit for monthly dosing over weekly
doi: 10.1177/0091270005278806
Also, anti-proliferative effects on smooth muscle cells and anti-inflammatory effects on macrophages may contribute to the protection against the development and progression of atherosclerosis [8-10]
